Parkinson’s Disease

The continuation of crucial supports and flexibilities — particularly involving testing and treatments — are key to protecting vulnerable elders in long-term care, the president and CEO of AHCA/NCAL...

Current antibody treatments may not protect against omicron variant, but new drugs are in development … Duodopa improves quality of life in late-stage Parkinson’s disease … CDC pours $22M into fighting...

When compared to alternative options, levodopa provides a superior risk-benefit profile when used to alleviate motor symptoms, and patients are less likely to stop treatment, according to the American...

Increases seen across all age groups, both sexes, various racial/ethnic groups, different urban/rural classifications

Longer lives don’t explain 63% rise in U.S. Parkinson’s mortality … NCAL updates booster vaccine kit for assisted living providers … Nearly all people with severe allergies can tolerate COVID-19...

No significant difference seen in rate of clinical disease progression or in secondary efficacy outcomes versus placebo

Survey: Most seniors approve of healthcare worker vaccinations … Depression levels rose among older adults during pandemic, survey shows … Alzheimer’s advocates urge HHS to adopt ‘aggressive’...

For the first time, scientists have grown tiny brains in laboratory dishes that mirror the major pathological features of Parkinson’s disease. The research offers a new way to learn how the disease progresses...

New ethics standards published for dementia caregivers … Parkinson’s disease quality measurement set update released … Early, awake prone positioning reduces intubation risk in acute COVID patients:...

Nursing homes recaptured $32M after reducing hospitalizations: study … Telehealth plus wearable tech allows better Parkinson’s symptom management … Non-invasive scan tech could help assess effectiveness...